Holoprosencephaly at prenatal diagnosis: analysis of 28 cases regarding etiopathogenic diagnoses
- PMID: 21706511
- DOI: 10.1002/pd.2796
Holoprosencephaly at prenatal diagnosis: analysis of 28 cases regarding etiopathogenic diagnoses
Abstract
Objective: To assess the likelihood of finding an etiopathogenic cause in an ultrasonographic prenatal diagnosis of holoprosencephaly.
Materials and methods: From January 1996 to June 2010, 13 883 prenatal diagnoses through chorionic villus sampling or amniocentesis were made. Every fetus with holoprosencephaly at ultrasound was evaluated. Gestational age, additional ultrasound findings, and fetal karyotype were recorded. Molecular diagnosis and parental karyotype were studied, if relevant.
Results: Twenty-eight fetuses were diagnosed with holoprosencephaly (0.20%). All cases had additional ultrasound findings (100%). A definitive etiology was found in 23 cases (82.14%): karyotype was abnormal in 19 (67.9%) and normal in 8 (28.5%) cases. In the normal karyotype group, although molecular testing was performed in a few cases, one mutation of gene SIX 3 was diagnosed, one diagnosis of dysgnathia complex was made, and two fetuses presented Smith-Lemli-Opitz syndrome. No etiopathogenic diagnosis was made in five fetuses.
Conclusions: Our results showed that a definitive etiology can be established in most cases of prenatal holoprosencephaly. Chromosomal anomalies were the most frequent finding. However, in euploid fetuses, molecular diagnosis is worthwhile, as different genes with different inheritance patterns may be responsible for this malformation. Thorough evaluation proved beneficial for assessing more accurate prognosis and recurrence risks.
Copyright © 2011 John Wiley & Sons, Ltd.
Similar articles
-
Prenatal diagnosis of holoprosencephaly associated with Smith-Lemli-Opitz syndrome (SLOS) in a 46,XX fetus.Taiwan J Obstet Gynecol. 2017 Aug;56(4):541-544. doi: 10.1016/j.tjog.2017.01.012. Taiwan J Obstet Gynecol. 2017. PMID: 28805615
-
The risk of recurrence of holoprosencephaly in euploid fetuses.Obstet Gynecol. 2007 Sep;110(3):658-62. doi: 10.1097/01.AOG.0000277633.21576.7e. Obstet Gynecol. 2007. PMID: 17766614
-
Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England.Am J Obstet Gynecol. 2001 May;184(6):1256-62. doi: 10.1067/mob.2001.111071. Am J Obstet Gynecol. 2001. PMID: 11349198
-
Genetic counseling and "molecular" prenatal diagnosis of holoprosencephaly (HPE).Am J Med Genet C Semin Med Genet. 2010 Feb 15;154C(1):191-6. doi: 10.1002/ajmg.c.30246. Am J Med Genet C Semin Med Genet. 2010. PMID: 20104616 Review.
-
Holoprosencephaly and chromosomal anomalies.Singapore Med J. 1996 Aug;37(4):394-7. Singapore Med J. 1996. PMID: 8993141 Review.
Cited by
-
Syndromes associated with holoprosencephaly.Am J Med Genet C Semin Med Genet. 2018 Jun;178(2):229-237. doi: 10.1002/ajmg.c.31620. Epub 2018 May 17. Am J Med Genet C Semin Med Genet. 2018. PMID: 29770994 Free PMC article.
-
Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis.Biomed Res Int. 2015;2015:426379. doi: 10.1155/2015/426379. Epub 2015 May 12. Biomed Res Int. 2015. PMID: 26064910 Free PMC article.
-
Smith-Lemli-Opitz syndrome - Fetal phenotypes with special reference to the syndrome-specific internal malformation pattern.Birth Defects Res. 2020 Jan 15;112(2):175-185. doi: 10.1002/bdr2.1620. Epub 2019 Dec 16. Birth Defects Res. 2020. PMID: 31840946 Free PMC article.
-
First trimester diagnosis of holoprosencephaly secondary to a ring chromosome 7.Case Rep Genet. 2013;2013:578202. doi: 10.1155/2013/578202. Epub 2013 Feb 21. Case Rep Genet. 2013. PMID: 23509645 Free PMC article.
-
Application of Single Nucleotide Polymorphism Microarray in Prenatal Diagnosis of Fetuses with Central Nervous System Abnormalities.Int J Gen Med. 2021 Aug 6;14:4239-4246. doi: 10.2147/IJGM.S323899. eCollection 2021. Int J Gen Med. 2021. PMID: 34393503 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources